GI & Endoscopy

A new endoscopy suite opened at Hendricks (Ind.) Regional Health's Danville hospital, the Hendricks County Flyer reported.

A new analysis from Kaiser Permanente networks in northern and southern California found nearly 70 percent of patients who died of colorectal cancer were not up to date on their screenings for the condition, Gastroenterology and Endoscopy News reported.

RedHill Biopharma's Crohn's disease drug, RHB-104, successfully met its primary and secondary endpoints, achieving remission at 26 weeks, Reuters reports.

Fight Colorectal Cancer and PGA Tour professional Tom Lehman are partnering to promote Fight CRC.

Researchers at Barcelona, Spain-based Hospital Del Mar Medical Research Institute discovered inhibiting the Jagged 1 protein in mice prevents colon and rectal tumor growth, according to research published in Nature Communications.

Here are the five most popular gastroenterology and endoscopy stories for the week of July 26 to August 1, 2018.

Takeda released its first quarter 2018 revenue numbers.

The American College of Gastroenterology released new recommendations for the treatment and management of Crohn's disease in adults, Medscape reported.

Researchers in Canada found using steroids before ulcerative colitis surgery is associated with a higher risk for postoperative sepsis and clotting, Gastroenterology & Endoscopy news reported.

Exact Sciences posted $102.9 million in second quarter 2018 revenue, missing investor predictions by $1.8 million, or 1.7 percent, causing its stock to fall 18.75 percent.